Med. praxi. 2026;23(4):235-242 | DOI: 10.36290/med.2026.035

Patient with dyspepsia in general practice

MUDr. Jan ©»ovíček, Ph.D.
Interní klinika FNMH a 2. LF UK, Praha
Klinika Restrial, Praha

Dyspepsia is a common clinical problem in primary care. The key task is to distinguish low-risk patients suitable for an empirical management strategy from those with alarm features or an increased risk of organic disease, in whom prompt diagnostic evaluation is indicated. Functional dyspepsia most commonly presents with postprandial fullness, early satiety, epigastric pain, or epigastric burning and may have a substantial impact on quality of life. The diagnostic approach is based on a careful medical history, physical examination, medication review, and appropriately targeted laboratory, imaging, and endoscopic investigations. In low-risk patients, treatment may be selected empirically according to the predominant symptom phenotype. In patients with alarm features, further diagnostic evaluation should not be delayed. For patients with a pain- or burning-predominant phenotype, a time-limited therapeutic trial of a proton pump inhibitor is appropriate, whereas lifestyle and dietary measures and prokinetic agents may be considered in patients with postprandial fullness, early satiety, and nausea. Treatment response should be reassessed within a short interval, and the diagnosis should be reconsidered in cases of treatment failure, symptom progression, or the development of alarm features.

Keywords: dyspepsia, functional dyspepsia, postprandial distress syndrome, epigastric pain syndrome, proton pump inhibitors, prokinetic agents.

Received: July 24, 2026; Revised: August 31, 2026; Accepted: August 31, 2026; Published: October 14, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
©»ovíček J. Patient with dyspepsia in general practice. Med. praxi. 2026;23(4):235-242. doi: 10.36290/med.2026.035.
Download citation

References

  1. Společnost vąeobecného lékařství ČLS JEP. Gastroenterologie - novelizace 2024. Doporučený postup pro vąeobecné praktické lékaře [Internet]. Praha: SVL ČLS JEP; 2024. Available from: https://svl.cz/svl-docs/doporucene-postupy/57/dp-gastro-2024.pdf.
  2. Moayyedi P, Lacy BE, Andrews CN, et al. ACG and CAG Clinical Guideline: Management of Dyspepsia. Am J Gastroenterol. 2017;112(7):988-1013. Go to original source...
  3. Black CJ, Paine PA, Agrawal A, et al. British Society of Gastroenterology guidelines on the management of functional dyspepsia. Gut. 2022;71(9):1697-723. Go to original source...
  4. Ford AC, Marwaha A, Sood R, et al. Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut. 2015;64(7):1049-57. Go to original source...
  5. Lee K, Kwon CI, Yeniova AÖ, et al. Global prevalence of functional dyspepsia according to Rome criteria, 1990-2020: a systematic review and meta-analysis. Sci Rep. 2024;14:4172. Go to original source...
  6. Rejchrt S, Koupil I, Kopáčová M, et al. Prevalence and sociodemographic determinants of uninvestigated dyspepsia in the Czech Republic. Eur J Gastroenterol Hepatol. 2008;20(9):898-905. Go to original source...
  7. Rejchrt S, Koupil I, Kopáčová M, et al. The prevalence and sociodemographic determinants of uninvestigated dyspepsia in the Czech Republic: a multicentre prospective study accomplished 10 years after the first study from the same geographical areas. Eur J Gastroenterol Hepatol. 2018;30(1):76-82. Go to original source...
  8. Stanghellini V, Chan FKL, Hasler WL, et al. Gastroduodenal disorders. Gastroenterology. 2016;150(6):1380-92. Go to original source...
  9. Wauters L, Dickman R, Drug V, et al. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia. United European Gastroenterol J. 2021;9(3):307-31. Go to original source...
  10. Zavoral M, Duąek L, Bureą J, et al. Souhrn důkazů: Časný záchyt karcinomu pankreatu. Analýza aktuálních vědeckých důkazů na úrovni doporučených postupů a systematických review [Internet]. Praha: Ministerstvo zdravotnictví ČR; 2025 [cit. 2026-08-18]. Available from: https://nikez.mzcr.cz/guideline/265-casny-zachyt-karcinomu-pankreatu/.
  11. Wang WH, Huang JQ, Zheng GF, et al. Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials. Clin Gastroenterol Hepatol. 2007;5(2):178-85. Go to original source...
  12. Malfertheiner P, Megraud F, Rokkas T, et al. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022;71(9):1724-62. Go to original source...
  13. Pittayanon R, Yuan Y, Bollegala NP, et al. Prokinetics for functional dyspepsia: a systematic review and meta-analysis of randomized control trials. Am J Gastroenterol. 2019;114(2):233-43. Go to original source...
  14. Qi Q, Wang N, Liu H, et al. Prokinetics for the treatment of functional dyspepsia: an updated systematic review and network meta-analysis. BMC Gastroenterol. 2023;23:370. Go to original source...
  15. Holtmann G, Talley NJ, Liebregts T, et al. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med. 2006;354(8):832-40. Go to original source...
  16. Talley NJ, Tack J, Ptak T, et al. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials. Gut. 2008;57(6):740-6. Go to original source...
  17. Du YQ, Su T, Song XM, et al. Efficacy and safety of cinitapride in the treatment of mild to moderate postprandial distress syndrome-predominant functional dyspepsia. J Clin Gastroenterol. 2014;48(4):328-35. Go to original source...
  18. Státní ústav pro kontrolu léčiv. Gapulsid 1 mg tablety: souhrn údajů o přípravku [Internet]. Praha: SÚKL. Dostupné z databáze léčivých přípravků SÚKL.European Medicines Agency. European Medicines Agency recommends changes to the use of metoclopramide [Internet]. Amsterdam: EMA; 2013 Jul 26 [cited 2026 Jul 12]. Dostupné z https://www.ema.europa.eu/en/news/european-medicines-agency-recommends-changes-use-metoclopramide.
  19. European Medicines Agency. PRAC recommends restricting use of domperidone Amsterdam: EMA; 2014 Mar 7. Available from: https://www.ema.europa.eu/en/news/prac-recommends-restricting-use-domperidone.
  20. Tack J, Ly HG, Carbone F, et al. Efficacy of mirtazapine in patients with functional dyspepsia and weight loss. Clin Gastroenterol Hepatol. 2016;14(3):385-92.e4. Go to original source...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.